Centessa Pharmaceuticals (CNTA)
(Delayed Data from NSDQ)
$9.54 USD
-0.32 (-3.25%)
Updated Jul 15, 2024 04:00 PM ET
After-Market: $9.56 +0.02 (0.21%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.39 |
EPS Last Quarter | -0.38 |
Last EPS Surprise | 7.32% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.67 |
Next Year | -1.61 |
EPS (TTM) | -1.42 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 6.85M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.39 | -0.39 | -1.67 | -1.61 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.41 | -0.42 | -1.68 | -1.78 |
High Estimate | -0.33 | -0.34 | -1.62 | -1.45 |
Low Estimate | -0.42 | -0.42 | -1.71 | -1.78 |
Year ago EPS | -0.26 | -0.40 | -1.57 | -1.67 |
Year over Year Growth Est. | -50.00% | 2.50% | -6.37% | 3.40% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.39 | -0.39 | -1.67 | -1.61 |
7 Days Ago | -0.39 | -0.39 | -1.67 | -1.61 |
30 Days Ago | -0.39 | -0.40 | -1.71 | -1.61 |
60 Days Ago | -0.41 | -0.41 | -1.72 | -1.66 |
90 Days Ago | -0.45 | -0.45 | -1.83 | -1.70 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.39 | -0.41 | -1.62 | -1.61 |
Zacks Consensus Estimate | -0.39 | -0.39 | -1.67 | -1.61 |
Earnings ESP | 0.00% | -5.13% | 2.99% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.38 | -0.38 | -0.40 | -0.26 | NA |
Estimate | -0.41 | -0.44 | -0.46 | -0.43 | NA |
Difference | 0.03 | 0.06 | 0.06 | 0.17 | 0.08 |
Surprise | 7.32% | 13.64% | 13.04% | 39.53% | 18.38% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more